ArTCell Artificial T-Cell
Artificial cell with T-Cell cytotoxic functionalities
ArTCell aims to leap innovation by providing a scalable, on-demand Artificial T-Cell substitute, by equipping an artificial cell with T cell cytotoxic functionalities. With this approach, the therapeutic product could be mass- manufactured from controlled raw materials, which is the most desirable route to obtain an off-the-shelf, cost-effective and safe anti-tumor cell therapy.
Limitations
Several major drawbacks, including economic factors, tumor-mediated inactivation, suboptimal functioning and life-threatening side effects are still hindering the full potential of T cell-based therapies.
Solution
Artificial T Cell (ArTCell): will mimic the anti-tumor function of T cell-based therapies while will be safer, more efficient, and less expensive to produce and handle.
Impact
ArTCell, a synthetically manufactured, off-shelf cell therapy, that will circumvent many of the current technological limitations that hinder a more widespread applicability of T Cell-based therapies, without being subject to tumor-mediated inactivation.
